Innate Pharma SA-Spons ADRIPHA
13F holders, Q3 2024 (September 30)8holders
0new positions
0sold out
1famous investor
$2.29avg. 13F price*
At the end of Q3 2024, 8 institutions reported holding Innate Pharma SA-Spons ADR (IPHA) in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holders were Optiver Holding B.V. ($199K), Exchange Traded Concepts, LLC ($177K) and Morgan Stanley ($100K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Innate Pharma SA-Spons ADR
- CUSIP
- 45781K204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 8,111 shares bought and 11,816 shares sold, net −3,705 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Optiver Holding B.V. | 0.01% | Reduce -0.7% | 86,788 | $199K |
| Exchange Traded Concepts, LLC | 0.00% | Reduce -10.3% | 77,350 | $177K |
| Morgan Stanley | 0.00% | No change | 43,524 | $100K |
| Citadel Advisors | 0.00% | Reduce -9.6% | 21,267 | $49K |
| UBS Group AG | 0.00% | Add +2731.0% | 8,408 | $19K |
| Barclays PLC | 0.00% | Reduce -25.5% | 307 | $703 |
| Rhumbline Advisers | 0.00% | No change | 205 | $469 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 200 | $458 |
"% of holder's portfolio" is IPHA's weight in each manager's 13F, not the share of Innate Pharma SA-Spons ADR the manager owns.